| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |